Passed in 1994, the Dietary Supplement Health & Education Act (DSHEA) established a strong, comprehensive regulatory framework for dietary supplements where none existed before. Nearly 30 years later, DSHEA should protect the 21st century consumer who has access to an ever-expanding dietary supplement marketplace. A modernized regulatory structure will protect public health and reinforce the credibility of the dietary supplement category, allowing it to play a more influential role in the healthcare system.
As consumers take control of their healthcare routines, more people are turning to dietary supplements to provide a boost to their wellbeing. Modernized regulations are needed to meet growing consumer demand, strengthen confidence in dietary supplements, and keep pace with the growth of the industry.
It’s a common misconception that the dietary supplements category is not regulated, when in fact it is regulated by multiple government agencies, with manufacturers and retailers also managing responsibility throughout the process.
Dietary supplement claims are a consumer's primary source of information about the product and its function. With a growing number of consumers new to the dietary supplements category, it is more important than ever for manufacturers to ensure the credibility of their claims in order to establish consumer trust.
October 25, 2021 marks the 27th anniversary of the Dietary Supplement Health and Education Act (DSHEA) being signed into law, establishing a regulatory framework for dietary supplements where no such system existed before.
It’s a common misconception that the dietary supplements category is not regulated, when in fact it is regulated by multiple government agencies, with manufacturers and retailers also managing responsibility throughout the process.
Join pioneers Patricia Knight, Scott Bass, and Loren Israelsen as they share stories on the founding of DSHEA and why the industry can benefit from its modernization 27 years later.
The dietary supplements segment has just experienced its largest annual growth rate since 1997. Hear from Dr. Pieter Cohen as he shares his insights on how modernization of DSHEA will help improve category compliance and credibility.
CHPA released the following statement in response to new research published in Clinical Toxicology. The study found nine illegal stimulants, including deterenol, in fraudulently marketed sports and weight loss supplements.
For its annual year-in-review series, Chain Drug Review featured CHPA's President & CEO, Scott Melville, who offered industry insights from last year and thoughts on the outlook for 2021.
CHPA released the following statement in response to FDA’s warning that consumers avoid certain male enhancement and weight loss products sold by major online retailers due to hidden, potentially dangerous drug ingredients.
